Blog Archives

Look for AfibAlert® at This Year’s American College of Cardiology Annual Expo in New Orleans, LA (ACC.19) for a Hands-on Demo of a Better Way to Screen for Afib

Lohman Technologies will be exhibiting at this year’s ACC.19 Expo in March 2019.  A highlight of the exhibit will be a hands-on demo of the newest version of the AfibAlert® Clinical Manager application.  This new app enables care providers to

Posted in Uncategorized

New Survey Reveals People with Atrial Fibrillation Prioritize Stroke Risk Reduction, Seek More Education on Treatment Options

Research was conducted by The Harris Poll on behalf of StopAfib.org and Boston Scientific Corporation StopAfib.org recently announced the results of a national online survey conducted by The Harris Poll of more than 400 people (aged 45 and older) living

Posted in Uncategorized

Patients with ‘Resolved’ AFib Maintain Elevated Stroke Risk

Atrial fibrillation (AFib) should never be considered fully cured, according to a recent study in The BMJ, because patients with this designation carry higher risks of stroke and death compared to people who have never had the arrhythmia. This finding is especially relevant

Posted in Uncategorized

How to Assess Your Risk of Developing AFib?

With atrial fibrillation (AFib) becoming so much more prevalent among the aging population and visible with all the advertising seen on TV for the new anticoagulants, it’s natural to wonder if you or any of your loved ones (husband, wife,

Posted in Uncategorized

Experts recommend screening for Atrial Fibrillation to reduce risk of stroke and death

New afib research from Circulation, the journal of the American Heart Association, demonstrates the importance of screening for atrial fibrillation. Screening for asymptomatic atrial fibrillation (AF or afib) in people aged 65 and over and treating it with anticoagulant medications

Posted in Uncategorized